Molnupiravir, a New Antiviral Drug for the Treatment of COVID-19

Molnupiravir, a New Antiviral Drug for the Treatment of COVID-19

Eurasian Journal of Critical Care

2022-Cilt: 4 - Sayı: 3

116-118

SARS-CoV-2, COVID-19, Molnupiravir

5118

Benzer Makaleler

Prospective Analysis of Application Reasons of Alzheimer's Patients Applying to the Emergency Department

Eurasian Journal of Critical Care

Murat ASLAN, Halil İbrahim ÇIKRIKLAR, Vahide Aslıhan DURAK, Serhat ATMACA, Suna ERAYBAR, Hakan ÇELEBİ, Erol ARMAGAN

EFFECT OF COVID-19 ON EMERGENCY SERVICE WORKERS

Eurasian Journal of Critical Care

Fatma SELMAN, Ertuğ GÜNSOY, Yeşim ŞENOL

Head Trauma In Refugee Children Under The Age Of 2

Eurasian Journal of Critical Care

Nalan CAVLAK ADSIZ, İlhami ADSIZ

Predictors of In-hospital Death in Patients with Stanford Type B Acute Aortic Dissection

Eurasian Journal of Critical Care

Murat DUYAN, Ali SARIDAŞ, Nafis VURAL

Is it Possible to Predict High-Risk Patients in Acute Pulmonary Embolism with Systemic Immune-Inflammation Index?

Eurasian Journal of Critical Care

Murat DUYAN, Ali SARIDAŞ, Nafis VURAL

Investigation of HBV, HCV, and HIV seropositivity in healthcare workers of reproductive age

Eurasian Journal of Critical Care

KOUNIS SYNDROME or ADRENALİN SIDE-EFFECT?

Eurasian Journal of Critical Care

Oya GÜVEN, Meziyet CAMUZ, Didar Elif AKGÜN, Mert AVSEVER

Primary Spotan Hemopneumothorax: A Case Report

Eurasian Journal of Critical Care

Mercan NİSA, Serdar ERGENÇ, Ahmet Taha ÖZATAK, Bahadir TASLİDERE, Basar CANDER